Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma

Clin Exp Allergy. 1992 Mar;22(3):337-44. doi: 10.1111/j.1365-2222.1992.tb03095.x.

Authors

M A Giembycz¹, G Dent

Affiliation

¹ Department of Thoracic Medicine, Royal Brompton National Heart and Lung Institute, London, U.K.

PMID: 1316796
DOI: 10.1111/j.1365-2222.1992.tb03095.x

No abstract available

Publication types

Review

MeSH terms

2',3'-Cyclic-Nucleotide Phosphodiesterases / antagonists & inhibitors*
Animals
Asthma / drug therapy*
Asthma / enzymology
Humans
Isoenzymes / antagonists & inhibitors*

Substances

Isoenzymes
2',3'-Cyclic-Nucleotide Phosphodiesterases